Abstract. A 46-year-old woman with rheumatoid arthritis had been on non-steroidal antiinflammatory agents for eighteen years until she developed cushingoid features and hypertension resistant to antihypertensive drugs. She had high plasma cortisol and 24 h urinary 17-hydroxycorticosteroids (17HCS) which were not suppressed by 8 mg dexamethasone per day for two days. The circadian rhythm of plasma cortisol was absent and plasma ACTH concentrations were suppressed before and after intravenous administration of CRH. Abdominal computed tomography demonstrated a tumor (3.0 x 3.0 x 2.3 cm) in the right adrenal gland and a 131I-6 /3-19-nor-methylcholesterol scan revealed marked uptake on the same side. The patient underwent a right adrenalectomy and the diagnosis of a cortisol secreting benign adenoma was histologically confirmed. Blood pressure declined and cushingoid features regressed, but three months after the operation and while the patient was on replacement, she complained of pain on motion, marked tenderness and swelling of fingers, wrists, elbows, knees and foot joints, and had very high rheumatoid factors. Treatment with immunosuppressive drugs and oral and intraarticular administration of glucocorticoids were necessary to relieve the clinical symptoms of rheumatoid arthritis. In summary, we report a patient with rheumatoid arthritis and Cushing's syndrome due to an adrenal adenoma, in whom rheumatoid arthritis was exacerbated after curing the Cushing's syndrome. This suggests that it is imperative to follow the development and/or course of autoimmune diseases after the treatment of Cushing's syndrome.
hypertension was noted. She also complained of rounding of the face and a weight gain of 10 kg in a few months. In July, 1991 she was admitted to the Kanto Rosai Hospital complaining of jaundice which remitted within a few weeks. During admission, low serum potassium (2.3 mEq/l) and high 24 h urinary 17HCS excretion were noted. She had been amenorrheic for the past 6 years after hysterectomy for myomatous uteri. She was referred to Toho University Hospital for evaluation for Cushing's syndrome. On admission, she weighted 66.5 kg for a height of 151 cm, her blood pressure was 160/120 mmHg under therapy with antihypertensive drugs (an ablocker, a calcium channel blocker and hypdralazine). She exhibited facial rounding, plethora, central obesity, buffalo hump, mild facial hirsutism and increased skin bruisability. There was edema on both legs, but no purplish skin striae on the abdomen or breasts. Slight swelling and light tenderness of the wrists and knee joints were noted bilaterally. Laboratory data revealed a hemoglobin level of 14.2 g/dl and a hematocrit value of 42.0%. Sodium, potassium, chloride, calcium, phosphorus, blood urea nitrogen, creatinine, total protein and albumin were all within normal limits, as were the liver function tests. CRP was negative and BSR was 30 mm/h. Rheumatoid factor was 53 IU/ml (normal, less than 10 IU/ml) and rheumatoid arthritis hemagglutination (RAHA) was 80 x (normal, less than 80 x). Circadian periodicity of the plasma cortisol concentrations was absent; plasma cortisol concentrations ranged from 414 to 516 nmol/L (normal 119-505 nmol/L). Plasma ACTH concentrations were undetectable (normal 4-22 pmol/L) ( Table 1) . Twenty four hour urinary free cortisol and 17HCS excretion were high, and 24 h were not suppressed by oral administration of low doses (0.5 mg every 6 h for 48 h) and high doses (2 mg every 6 h for 48 h) of dexamethasone. Intravenous administration of ACTH 0.25 mg (Cortrosyn ®, Daiichi Pharmaceutical Co., Tokyo) was followed by a plasma cortisol increase from 612 nmol/L to 1556 nmol/L at 120 min and by an aldosterone increase from 287 pmol/L to 892 pmol/L at 30 min. Plasma cortisol and ACTH after 100 jig CRH administration were unchanged, with the latter remaining undetectable. Additional studies revealed a slightly low free T4 of 9.65 pmol/L and normal TSH of 1.9 mU/L, and normal 24 h urinary catecholamine excretion. Plasma estrone (E1) and estradiol (E2) concentrations were within the normal range and serum LH and FSH concentrations were slightly high. X-rays of the skull showed a normal sella turcica and a computed tomographic scan (CT) of the sella turcica area showed no abnormality. Gamma camera imaging after the intravenous injection of 1 mCi 1311-6/3-19-nor-methylcholesterol revealed marked isotopic uptake in the right adrenal gland which was not suppressed by treatment with 3 mg/day of dexamethasone for ten days. Abdominal CT scan demonstrated a tumor (3.0 x 3.0 x 2.3 cm) in the right adrenal gland and an atrophic left adrenal gland. From these endocrinological findings we diagnosed Cushing's syndrome due to a right adrenal adenoma. At unilateral right adrenalectomy, a round 2.5 cm diameter, 8.0 g encapsulated adenoma was removed. Microscopic examination revealed no areas of capsular or blood vessel invasion, consistent with a benign adrenocortical adenoma. The tumor consisted mainly of large clear cells and partially of small eosinophilic cells with a slight nuclear pleomorphism. There was a slight infiltration of the tumor by lymphocytes.
Postoperative glucocorticoid therapy consisted of parenteral hydrocortisone hemisuccinate (200 to 30 mg/day) for six days and oral hydrocortisone 30 mg/day, tapered to 15 mg/day two weeks after the operation. After ten weeks of a substitutive hydrocortisone therapy she began to complain of tenderness in the wrists joints. Rheumatoid factor was 43.2 IU/m1 just before adrenalectomy and increased to 88.3 IU/ml two months after and to 282.5 IU/ml three months after the operation. RAHA was 80 x preoperatively, also increased to 160 x two months after and to 640 x three months after the operation. BSR was 34 mm/h one month after the operation. Plasma cortisol concentrations were within normal range and plasma ACTH increased to 4.0 pmol/L three months after the operation. Pain on motion and marked tenderness in the bilateral proximal interphalangeal and metacarpophalangeal, wrist, elbow, knee and foot joints occurred. Symmetric swelling of the same joints and ulnar deviation of the fingers developed. Radiologically periarticular osteoporosis, joint space narrowing and marginal erosion with soft tissue swelling were observed in the bilateral proximal interphalangeal and metacarpophalangeal, wrist, elbow, knee and foot joints.
The patient was started on nonsteroidal antiinflammatory therapy and oral gold compound X-ray films of interphalangeal, metacarpophalangeal and wrist joints. A: before removal of adenoma.
B: after removal. Periarticular osteoporosis, joint space narrowing and marginal erosion were marked in the bilateral proximal interphalangeal, metacarpophalangeal and wrist joints after removal of adrenal adenoma.
(auranofin 3 mg once daily). As symptoms persisted the patient was treated further with immunosuppressive drugs (methotrexate 2.5 mg/ day), prednisolone 10 mg on alternate days and intraarticular injections of triamcinolone acetonide 40 mg once a month. Antimicrosomal and antithyroglobulin antibodies were positive in serum at a dilution of 1:100 and 1:100 preoperatively, which increased to 1:400 and to 1:1600, respectively, two or three months after right adrenalectomy. Blood pressure declined from 142-160/100-120 mmHg preoperatively to 132/86 mmHg ten days after surgery. Cushingoid features regressed in three months. Recently, the possibility that stimulating antibodies play a role in the pathogenesis of Cushing's In the present paper we report a patient with both rheumatoid arthritis and Cushing's syndrome due to an adrenal adenoma.
We are tempted to speculate that the autoimmune mechanism relates not only to the development of rheumatoid arthritis but also of Cushing's syndrome, and that autoantibodies directed against the ACTH receptor might have caused Cushing's syndrome. But the circulating adrenal antibodies are likely to stimulate both adrenal glands, so we need to follow changes in the other adrenal gland.
In summary, we report a patient with rheumatoid arthritis and Cushing's syndrome due to an adrenal adenoma, in whom rheumatoid arthritis was exacerbated by treatment for Cushing's syndrome.
It is necessary to follow the development and/or course of autoimmune disease after treatment for Cushing's syndrome because they may deteriorate during this period.
